Subscribe to Newsletter

Beyond "Disease X": Strategic R&D in an Era of Emerging Threats

sponsored by Biosynth

Register here

October 30, 2024 01:00 PM US/Eastern
 

Join Biosynth for their fascinating webinar on emerging infectious diseases, like COVID-19 and Ebola which pose an ever-present threat to global health. The World Health Organization's R&D Blueprint is a crucial tool in this ongoing battle, prioritizing research and development for pathogens with the highest potential to cause widespread epidemics. However, limited resources and the specter of unknown "Disease X" threats underscore the urgency and complexity of this task.

Register here

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Related White Papers
Nitrosamines Risk Mitigation: The critical role of excipients and supplier qualification

| Contributed by DFE Pharma GmbH & Co. KG

It's a matter of taste!

| Contributed by GalenIQ

MDRS used to confirm the pharmaceutical equivalence of Oral Solid Dose (OSD) products

| Contributed by Malvern Panalytical

Related Event
-
Discover Cutting-Edge Pharma Innovations at INTERPHEX – Network, Learn, and Innovate Now!

New York, USA

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register